Clinical Trials
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9916
Docetaxel and Estramustine Versus Mitoxantrone and Prednisone for Advanced, Hormone Refractory Prostate Cancer, Phase III.
Research Committee(s)
Genitourinary Cancer
Activated
10-15-1999
Closed
01-15-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9812
Pilot Study of l-Selenomethionine in Prostate Cancer Patients Scheduled to Undergo Radical Prostatectomy
Activated
06-15-1999
Closed
06-01-2001
Closed
Phase
Accrual
60%
Published
SWOG Clinical Trial Number
S9804
Evaluation of Vinorelbine Tartrate (Navelbine®) in Patients with Disseminated Malignant Melanoma and at Least One Prior Systemic Therapy, Phase II.
Research Committee(s)
Melanoma
Activated
05-15-1999
Closed
08-01-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9911
A Phase II Pilot Trial of CHOP Followed By Iodine-131-Labeled Monoclonal Anti-B1 Antibody for Treatment of Newly Diagnosed Follicular Non-Hodgkin’s Lymphomas
Research Committee(s)
Lymphoma
Activated
05-15-1999
Closed
06-01-2000
Closed
Phase
Accrual
13%
Published
SWOG Clinical Trial Number
S9809
The Effect of Fluoroquinolones on the Disease-Free Interval in Patients with Stage Ta Transitional Cell Carcinoma of the Bladder, Phase III
Research Committee(s)
Genitourinary Cancer
Activated
04-15-1999
Closed
07-01-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9810
A Phase II Study of Gemcitabine and Cisplatin in Unresectable Malignant Mesothelioma
Research Committee(s)
Sarcoma
Activated
02-15-1999
Closed
08-15-2000
Closed
Phase
Accrual
66%
Published
SWOG Clinical Trial Number
S9811
Phase II Study of Hydroxyurea for Unresectable Meningioma
Activated
11-15-1998
Closed
06-01-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9806
Randomized Phase II Trial of Carboplatin/Gemcitabine Followed by Paclitaxel or Cisplatin/Vinorelbine Followed by Docetaxel in Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
11-01-1998
Closed
11-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9717
Evaluation of Intravenously Administered Tirapazamine Plus Cisplatin in Cervical Cancer, Phase II.
Research Committee(s)
Gynecologic Cancer
Activated
08-15-1998
Closed
08-15-2000
Closed
Phase
Accrual
75%
Published
SWOG Clinical Trial Number
S9803
The Evaluation of Gemcitabine (Gemzar®) in Resistant and Relapsing Multiple Myeloma, Phase II
Activated
08-15-1998
Closed
12-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9832
Enhancing Well-Being During Breast Cancer Recurrence
Research Committee(s)
Breast Cancer
Activated
07-15-1998
Closed
11-15-2002
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9718
A Phase II Trial of Gemcitabine Plus Cisplatin in Patients With Extensive Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
07-01-1998
Closed
06-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9713
A Phase II Trial of Cisplatin/Etoposide and Concurrent, Radiotherapy Followed by Paclitaxel/Carboplatin Consolidation For Limited Stage Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
07-01-1998
Closed
08-01-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9802
A Phase II Trial of Gemcitabine in Advanced Soft Tissue Sarcomas
Activated
05-01-1998
Closed
03-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9626
Closed
Phase
Accrual
49%
Published
SWOG Clinical Trial Number
S9635
A Phase II Trial of 5-fluorouracil Plus 776C85 in Patients With Advanced Resistant Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
04-01-1998
Closed
09-15-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9801
Evaluation of Gemcitabine - Cisplatin Combination Chemotherapy in Esophageal Carcinoma.
Activated
04-01-1998
Closed
06-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9720
Phase II Trial of Paclitaxel and Carboplatin with Amifostine in Advanced Recurrent or Refractory Endometrial Adenocarcinoma
Research Committee(s)
Gynecologic Cancer
Activated
02-15-1998
Closed
07-15-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9712
Phase II Trial of Concurrent Carboplatin/VP-16 and Radiation Followed by Paclitaxel (Taxol®) For Poor-Risk Stage III Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
02-15-1998
Closed
06-01-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9800
A Phase II Pilot Trial of CHOP Followed by Rituximab Chimeric Monoclonal Anti-CD20 Antibody for Treatment of Newly Diagnosed Follicular Non-Hodgkin’s Lymphomas
Research Committee(s)
Lymphoma
Activated
02-15-1998
Closed
11-15-1998